Skip to main content

Find Clinical Trials

Home
Conditions
Urogenital Diseases

Clinical trial condition

Urogenital Diseases

Explore clinical trials studying Urogenital Diseases. Study availability and eligibility vary by location and protocol.

40,168 public trials 6,127 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Diseases trial results

Recruiting

Male Sexual Function and Sexual Quality of Life in Polygamous Versus Monogamous Marriages

NCT07783958

Conditions: Erectile Dysfunction, Genital Diseases, Genital Diseases, Male, +6 more
Locations: Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University Cairo, Egypt

View Trial Details

Recruiting

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

NCT06978127

Conditions: Behavior, Behavioral Symptoms, Chronic Disease, +17 more
Locations: UNM Albuquerque, New Mexico, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

NCT04303117

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Measuring Adverse Pregnancy and Newborn Congenital Outcomes

NCT04405700

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations: Moi Teaching and Referral Hospital Eldoret, Kenya

View Trial Details

Recruiting

Hypofractionated Chemoradiotherapy for Cervical Cancer

NCT07709650

Conditions: Cervival Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Siriraj Hospital Bangkok Noi, Bangkok, Thailand

View Trial Details

Recruiting

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

NCT05825950

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

NCT07053800

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: State University of New York Upstate Medical Center (SUNY) Syracuse, New York, United States

Texas Transplant Institute San Antonio, Texas, United States

University General Hospital ATTIKON Athens, Greece

University General Hospital of Patras Pátrai, Greece

View all 15 locations

View Trial Details

Recruiting

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

NCT07456865

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations: Urology Centers of Alabama Homewood, Alabama, United States

Rosemark Women Care Specialists Idaho Falls, Idaho, United States

Urology of Saint Louis St Louis, Missouri, United States

Urology Specialists of the Carolinas Greensboro, North Carolina, United States

View Trial Details

Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

NCT06218914

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +32 more
Locations: Research Site Duarte, California, United States

Research Site Los Angeles, California, United States

Research Site Newport Beach, California, United States

Research Site Jacksonville, Florida, United States

View all 18 locations

View Trial Details

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

NCT06136650

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: The University of Arizona Cancer Center - North Campus ( Site 0073) Tucson, Arizona, United States

UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040) Orange, California, United States

Stanford Cancer Center ( Site 0036) Palo Alto, California, United States

View all 330 locations

View Trial Details